No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Distribution
Jointown Pharmaceutical Group Co., Ltd engages in pharmaceutical distribution and supply chain business in China and internationally. It is also involved in general agency brand promotion; pharmaceutical industrial self-production and OEM; and pharmaceutical new retail and ten-thousand store alliance plan businesses. In addition, the company provides medical health and technology value-added services; and digital logistics and supply chain solutions. The company was founded in 1999 and is headquartered in Wuhan, China.
www.jointown.comNo one on the platform currently holds 600998.SS.
No tracked institution reports a position in 600998.SS as of their last filing.
No one on the platform has traded 600998.SS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 4.0% | 9.8% | 9.3% | — | — | — |
| Rev. Growth % | 6.3% | 7.8% | ||||
| Profit Margin % | 1.4% | 1.6% | 1.7% | |||
| Free Cash Flow Margin % | 1.3% | 1.8% | 0.7% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $172.0B | +7.5% | $0.44 | $0.43–$0.46 | — | 3 |
| 2027 | $183.1B | +6.4% | $0.48 | $0.46–$0.50 | — | 3 |
| 2028 | $194.5B | +6.3% | $0.53 | $0.47–$0.60 | — | 4 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 3 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-24 | $0.11 | $0.09 | -17.9% |
| 2026-04-27 | $0.18 | $0.06 | -67.9% |
| 2026-04-27 | $0.23 | $0.14 | -39.1% |
| 2025-10-27 | $0.10 | $0.11 | +8.6% |
| 2025-08-26 | $0.14 | $0.09 | -32.6% |
| 2025-04-28 | $0.11 | $0.16 | +45.2% |
| 2025-04-28 | $0.11 | $0.19 | +74.7% |
| 2024-10-28 | $0.10 | $0.09 | -10.0% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 600998.SSJointown Pharmaceutical Group Co., Ltd. | $4.94 | -1.59% | $24.9B | — |
| 000623.SZJilin Aodong Pharmaceutical Group Co., Ltd. | $17.34 | -0.34% | $20.7B | — |
| 002262.SZJiangsu Nhwa Pharmaceutical Co., Ltd. | $21.52 | -0.60% | $21.9B | — |
| 300677.SZIntco Medical Technology Co., Ltd. | $51.27 | -4.53% | $33.6B | — |
| 300888.SZWinner Medical Co., Ltd. |
| $28.15 |
| -0.64% |
| $16.4B |
| — |
| 600329.SSTianjin Pharmaceutical Da Ren Tang Group Corporation Limited | $33.96 | -0.35% | $19.4B | — |
| 600511.SSChina National Medicines Corporation Ltd. | $26.09 | -0.61% | $19.7B | — |
Source: Financial Modeling Prep · peers by sector/industry